Suchergebnisse - "Markowski, Mark C"

PubPharm (8)

1

Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer

enthalten in: The oncologist | 2023

von Denmeade, S. | Sena, L. | Wang, H. | +2

2

Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC

enthalten in: The Journal of clinical investigation | 2022

von Sena, L. | Kumar, R. | Sanin, D. | +22

3

Bipolar androgen therapy (BAT) : A patient's guide

enthalten in: The Prostate | 2022

von Denmeade, S. | Antonarakis, E. | Markowski, M.

4

Supraphysiologic Testosterone Induces Ferroptosis and Activates Immune Pathways through Nucleophagy in Prostate Cancer

enthalten in: Cancer research | 2021

von Kumar, R. | Mendonca, J. | Owoyemi, O. | +22

CommentIn: Nat Rev Urol. 2021 Dec;18(12):706. - PMID 34741154

5

A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE) : A Comparison of Post-abiraterone Versus Post-enzalutamide Cohorts

enthalten in: European urology | 2021

von Markowski, M. | Wang, H. | Sullivan, R. | +13

6

TRANSFORMER : A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Denmeade, S. | Wang, H. | Agarwal, N. | +25

7

Bipolar androgen therapy sensitizes castration-resistant prostate cancer to subsequent androgen receptor ablative therapy

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Sena, L. | Wang, H. | Lim ScM, S. | +12

CommentIn: Eur J Cancer. 2023 Mar;181:23-25. - PMID 36628897

8

Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer

enthalten in: The Prostate | 2020

von Markowski, M. | Shenderov, E. | Eisenberger, M. | +4

1
[1]